Structure	Catalog	Product Name	CAS	E3 Ligase	Target	Inquiry
	BPL-201533	LC-5	2502156-30-9	VHL	KRAS G12C	Inquiry
Molecular Weight: 1162.83 Molecular Formula: C60H73ClFN11O8S Density: 1.297±0.06 g/cm3 Description: It is a VHL-recruiting PROTAC that targets the degradation of oncogenic KRASG12C.
	BPL-201534	LC-6	2725912-34-3	VHL	KRAS G12C	Inquiry
Molecular Weight: 1189.86 Molecular Formula: C61H74ClFN12O8S Density: 1.304±0.06 g/cm3 Description: It is a VHL-recruiting PROTAC that targets the degradation of oncogenic KRASG12C.
	BPL-201535	2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-N-(4-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-4-oxobutyl)acetamide	2523016-40-0	CRBN	PARP1	Inquiry
Molecular Weight: 765.76 Molecular Formula: C39H36FN7O9 Density: 1.53±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201536	2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-N-(6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexyl)acetamide	2523016-43-3	CRBN	PARP1	Inquiry
Molecular Weight: 793.81 Molecular Formula: C41H40FN7O9 Density: 1.49±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201537	4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)-N-(4-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-4-oxobutyl)butanamide	2523016-47-7	CRBN	PARP1	Inquiry
Molecular Weight: 850.86 Molecular Formula: C43H43FN8O10 Density: 1.51±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201538	6-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)-N-(4-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-4-oxobutyl)hexanamide	2523016-54-6	CRBN	PARP1	Inquiry
Molecular Weight: 878.92 Molecular Formula: C45H47FN8O10 Density: 1.47±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201539	4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)-N-(6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexyl)butanamide	2523016-58-0	CRBN	PARP1	Inquiry
Molecular Weight: 878.92 Molecular Formula: C45H47FN8O10 Density: 1.47±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201540	6-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)-N-(6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexyl)hexanamide	2523016-62-6	CRBN	PARP1	Inquiry
Molecular Weight: 906.97 Molecular Formula: C47H51FN8O10 Density: 1.44±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201541	4-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)acetamido)-N-(6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexyl)butanamide	2523016-74-0	CRBN	PARP1	Inquiry
Molecular Weight: 877.93 Molecular Formula: C45H48FN9O9 Density: 1.47±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201542	6-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)acetamido)-N-(6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexyl)hexanamide	2523016-76-2	CRBN	PARP1	Inquiry
Molecular Weight: 905.99 Molecular Formula: C47H52FN9O9 Density: 1.44±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201543	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-6-oxohexanamide	2523016-92-2	CRBN	PARP1	Inquiry
Molecular Weight: 792.83 Molecular Formula: C41H41FN8O8 Density: 1.50±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201544	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-8-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-8-oxooctanamide	2523016-93-3	CRBN	PARP1	Inquiry
Molecular Weight: 820.88 Molecular Formula: C43H45FN8O8 Density: 1.46±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201545	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-10-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-10-oxodecanamide	2523016-94-4	CRBN	PARP1	Inquiry
Molecular Weight: 848.93 Molecular Formula: C45H49FN8O8 Density: 1.43±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201546	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-11-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-11-oxoundecanamide	2523016-95-5	CRBN	PARP1	Inquiry
Molecular Weight: 862.96 Molecular Formula: C46H51FN8O8 Density: 1.41±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201547	SK-575	2523016-96-6	CRBN	PARP1	Inquiry
Molecular Weight: 876.99 Molecular Formula: C47H53FN8O8 Density: 1.40±0.1 g/cm3 Description: SK-575 is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201548	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-13-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-13-oxotridecanamide	2523016-97-7	CRBN	PARP1	Inquiry
Molecular Weight: 891.01 Molecular Formula: C48H55FN8O8 Density: 1.39±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201549	N-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-14-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-14-oxotetradecanamide	2523016-98-8	CRBN	PARP1	Inquiry
Molecular Weight: 905.04 Molecular Formula: C49H57FN8O8 Density: 1.38±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201550	N-(4-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)-12-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-12-oxododecanamide	2523016-90-0	CRBN	PARP1	Inquiry
Molecular Weight: 905.04 Molecular Formula: C49H57FN8O8 Density: 1.38±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201551	N-(6-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)-12-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-12-oxododecanamide	2523016-99-9	CRBN	PARP1	Inquiry
Molecular Weight: 933.10 Molecular Formula: C51H61FN8O8 Density: 1.35±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.
	BPL-201552	N-(2-(2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethyl)-12-(4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazin-1-yl)-12-oxododecanamide	2523017-00-5	CRBN	PARP1	Inquiry
Molecular Weight: 921.04 Molecular Formula: C49H57FN8O9 Density: 1.39±0.1 g/cm3 Description: It is a highly potent and efficacious proteolysis-targeting chimera degrader of PARP1 for cancers treatment.

PROTAC Library